Literature DB >> 31647462

Risk behaviour and patient preferences for an improved non-melanoma skin cancer prevention modality for organ-transplanted patients: a European, multi-country, online patient community study.

Nicole Basset Seguin1, Josep Malvehy2, Florence Nadal3, Laurent Creancier3, Isabelle Rauly-Lestienne3, Roxane Beauchamp3, Marjan Hezareh3, Anne-Marie Schmitt3, Liliana Ulianov3.   

Abstract

Immunosuppressants used in organ transplant patients increase the risk of non-melanoma skin cancer. This study aimed to evaluate patient behaviours towards skin cancer prevention methods and to understand characteristics of a future prevention strategy based on patients' perspective. Carenity, a global online patient community, enabled the recruitment of 200 adult patients with solid organ transplants from four European countries: France, Italy, Spain and Germany. Most patients were well informed about the risk of skin cancer, but only 27% (53/200) monitored their skin. Most patients exposed themselves to intense sun exposure once a month or more. Nevertheless, more than half of patients were motivated to use additional prevention strategies and limit their sun exposure. The most appropriate prevention strategy was reported to be the use of a cosmetically attractive, water-resistant, paraben/fragrance-free cream. A one-size-fits-all approach is not an appropriate prevention strategy and an adapted approach based on patients' preferences may significantly contribute to better compliance and adherence.

Entities:  

Keywords:  NMSC; keratinocyte cancer; non-melanoma skin cancer; organ transplantation; preventive treatment; skin protection

Mesh:

Substances:

Year:  2019        PMID: 31647462     DOI: 10.1684/ejd.2019.3639

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  1 in total

1.  Chronic patients' satisfaction and priorities regarding medical care, information and services and quality of life: a French online patient community survey.

Authors:  Apolline Adé; Frédérique Debroucker; Laura Delporte; Cécile De Monclin; Emmanuel Fayet; Pierre Legendre; Lise Radoszycki; Michael Chekroun
Journal:  BMC Health Serv Res       Date:  2020-06-05       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.